PURE Bioscience, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | 56.1% | -62.5% | -62.7% |
| FY2022 | 55.2% | -205.4% | -192.6% |
| FY2023 | 51.9% | -210.7% | -211.7% |
| FY2024 | 58.9% | -163.2% | -171.4% |
| FY2025 | 59.3% | -103.4% | -109.1% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | 56.1% | -62.5% | -62.7% |
| FY2022 | 55.2% | -205.4% | -192.6% |
| FY2023 | 51.9% | -210.7% | -211.7% |
| FY2024 | 58.9% | -163.2% | -171.4% |
| FY2025 | 59.3% | -103.4% | -109.1% |